Synchrony dual optic accommodating lens dating a photojournalist

Many surgeons and patients currently forego choosing a multifocal IOL because of unwanted images at night,the slight reduction in contrast sensitivity, and a limited range of intermediate vision," Dr. "The hope with an accommodating lens is to be able to accomplish the upside of some reading ability without any optical drawbacks in comparison to a monofocal lens." Dr.

Chang says that for any moving optic, the resulting amount of accommodative shift is proportional to the dioptric power of the IOL.

synchrony dual optic accommodating lens-32

I could always see the tiniest birds at the top of trees.

But three years ago, my sight started getting very blurred.

It is the only implant in the world which expands and contracts naturally to give a continuous change in focus without compromising the quality of vision – just like our natural lens when we are young.

The London Eye Hospital is proud to be able to provide each patient with a choice of all the latest premium lens implants.

TECNIS® Symfony IOL is the first and only presbyopia-correcting extended range of vision IOL.

In the search for the best presbyopia treatment, a lot of attention has been paid to multifocal and diffractive intraocular lenses, while there's been little movement on the accommodating IOL front.

End-Stage AMD is the most advanced form of the disease and the leading cause of irreversible vision loss and legal blindness in individuals over the age of 65.

In early, less advanced AMD, visual symptoms are generally mild and may or may […] CLICK HERE TO READ THE REST…

The Synchrony is the first dual-optic accommodating IOL, and is a single-piece silicone lens that has a high-powered 32 D anterior optic joined to a rear minus-powered optic by flexible silicone spring-like struts.

The medical monitor for the "Ophthalmologists and patients want improved accommodating lenses that can reduce spectacle dependence without the inherent drawbacks of multifocality.

That may change in the next year, as the clinical investigators and company researchers at Visiogen are readying their Phase III data for the Synchrony dual-optic accommodating IOL for submission to the Food and Drug Administration.

Tags: , ,